Jakobsen A, Nyberg G
Kirurgisk avdeling B, Rikshospitalet, Oslo.
Nord Med. 1994;109(12):321-3.
In the Nordic countries, the annual figures for new patients scheduled for renal replacement therapy (i.e., dialysis or kidney transplantation) are 49 (Denmark), 55 (Finland), 65 (Norway) and 99 (Sweden) per million of the population (pmp). Some 40-50 of those patients are medically eligible for transplantation. If the transplant rate of the individual transplant centre or country is less, the waiting list will increase, as they do at some of the Nordic centres. The annual rate of transplants from living related donors, including spouses, varies from almost zero in Finland to nearly 20 pmp in Norway. The average age of recipients has increased with the increasing age of patients accepted for dialysis. Of the Nordic countries, Norway has the highest acceptance rate of patients above the age of 70, whereas dialysis is the preferred treatment for most of the elderly patients in the other Nordic countries. During the period 1989-93, death with a functioning kidney accounted for nearly half the graft losses in the Norwegian transplant population, and graft rejection for 37 percent. Cardiovascular disease was a predominant cause of death.
在北欧国家，计划接受肾脏替代治疗（即透析或肾移植）的新患者年度数据为每百万人口（pmp）中，丹麦有49例、芬兰有55例、挪威有65例、瑞典有99例。其中约40 - 50例患者在医学上符合移植条件。如果个别移植中心或国家的移植率较低，等待名单就会增加，北欧的一些中心就是如此。包括配偶在内的亲属活体供者的年移植率，从芬兰的几乎为零到挪威的近20 pmp不等。随着接受透析患者年龄的增加，受者的平均年龄也在上升。在北欧国家中，挪威对70岁以上患者的接受率最高，而在其他北欧国家，透析是大多数老年患者的首选治疗方式。在1989 - 1993年期间，挪威移植人群中，移植肾仍在发挥功能时的死亡占移植肾丢失的近一半，移植排斥占37%。心血管疾病是主要死因。
